Work

Supplementary Figure S1 from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Year: 2023

Type: supplementary-materials

Abstract: NECTIN4 mRNA gene expression across the (A) TCGA, (B) Decipher, and (C) Lund molecular subtypes in the Decipher commercial cohort (n=529). The p value from Kruskal-Wallis testing is shown for each panel.

DOI: 10.1158/1078-0432.22481595

Authors: Carissa E. Chu, Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu, Vadim S. Koshkin, Bradley A. Stohr, Maxwell V. Meng, Raj S. Pruthi, Terence W. Friedlander, Yair Lotan, Peter C. Black, Sima P. Porten, Felix Y. Feng, Jonathan Chou

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361890208

Cites:

Cited by:

Related to: 10